These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31602234)

  • 21. DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS?
    Laurito MP; Silva GF; Cheinquer H; Sharma R; Verna E; Parise ER
    Arq Gastroenterol; 2018; 55(2):179-183. PubMed ID: 30043870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.
    Abd El-Wahab EW; Mikheal A; Sidkey F; Shatat HZ
    J Med Virol; 2015 Mar; 87(3):428-40. PubMed ID: 25583244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.
    Serfaty L; Forns X; Goeser T; Ferenci P; Nevens F; Carosi G; Drenth JP; Lonjon-Domanec I; DeMasi R; Picchio G; Beumont M; Marcellin P
    Gut; 2012 Oct; 61(10):1473-80. PubMed ID: 22387529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance.
    Khattab M; Emad M; Abdelaleem A; Eslam M; Atef R; Shaker Y; Hamdy L
    Liver Int; 2010 Mar; 30(3):447-54. PubMed ID: 19919569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pegylated interferon plus ribavirin therapy improves pancreatic β-cell function in chronic hepatitis C patients.
    Huang JF; Dai CY; Yu ML; Huang CF; Huang CI; Yeh ML; Yang JF; Hou NJ; Hsiao PJ; Lin ZY; Chen SC; Shin SJ; Chuang WL
    Liver Int; 2011 Sep; 31(8):1155-62. PubMed ID: 21745292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A virological response study of serum leptin level and insulin resistance on the antivirus effect in patients with chronic hepatitis C].
    Zhu B; Zhang P; Wang XH; Sun LH; Jiang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):887-9. PubMed ID: 17196129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of insulin resistance on the development of hepatocellular carcinoma after antiviral treatment for non-cirrhotic patients with chronic hepatitis C.
    Hayashi T; Ogawa E; Furusyo N; Murata M; Hayashi J
    Infect Agent Cancer; 2016; 11():9. PubMed ID: 26913058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
    Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
    Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV treatment with direct acting antivirals improves the insulin sensitivity.
    Alsebaey A; Elhelbawy M; Abdel-Razek W; Hashim M; Elshenawy H; Waked I
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):749-754. PubMed ID: 31393188
    [No Abstract]   [Full Text] [Related]  

  • 30. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients.
    Degasperi E; Valenti L; Aghemo A; De Francesco R; Rumi M; Soffredini R; Donnici L; Cheroni C; Fargion S; Zanoni V; Orsi E; Colombo M
    Antivir Ther; 2014; 19(8):747-53. PubMed ID: 24523350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy.
    Chien CH; Lin CL; Hu CC; Chang JJ; Chien RN
    J Interferon Cytokine Res; 2015 Dec; 35(12):981-9. PubMed ID: 26308911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon alpha-2a and ribavirin.
    Yu JW; Wang GQ; Sun LJ; Li XG; Li SC
    J Gastroenterol Hepatol; 2007 Jun; 22(6):832-6. PubMed ID: 17565637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
    Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
    Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis.
    Thong VD; Poovorawan K; Tangkijvanich P; Wasitthankasem R; Vongpunsawad S; Poovorawan Y
    Intervirology; 2015; 58(6):373-81. PubMed ID: 27010195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.
    Conjeevaram HS; Wahed AS; Afdhal N; Howell CD; Everhart JE; Hoofnagle JH;
    Gastroenterology; 2011 Feb; 140(2):469-77. PubMed ID: 21070775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of metformin on the efficacy of antiviral therapy in patients with genotype 1 chronic hepatitis C and insulin resistance.
    Yu JW; Sun LJ; Zhao YH; Kang P; Yan BZ
    Int J Infect Dis; 2012 Jun; 16(6):e436-41. PubMed ID: 22486858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between insulin resistance and outcome of pegylated interferon and ribavirin therapy, hepatic steatosis, hepatic fibrosis in chronic hepatitis C-1b and high viral load.
    Kim SR; Saito J; Imoto S; Komaki T; Nagata Y; Nakajima T; Ando K; Fukuda K; Otono Y; Kim KI; Ohtani A; Sugimoto K; Hasegawa Y; Fujinami A; Ohta M; Hotta H; Maekawa Y; Hayashi Y; Kudo M
    Digestion; 2011; 84 Suppl 1():5-9. PubMed ID: 22156479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.
    Younossi Z; Negro F; Serfaty L; Pol S; Diago M; Zeuzem S; Andreone P; Lawitz EJ; Roberts S; Focaccia R; Foster GR; Horban A; Lonjon-Domanec I; Coate B; DeMasi R; Picchio G; Witek J
    Hepatology; 2013 Dec; 58(6):1897-906. PubMed ID: 24382638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.